Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.6 - $4.17 $41,358 - $66,332
-15,907 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$3.64 - $7.78 $57,901 - $123,756
15,907 New
15,907 $58,000
Q2 2021

Aug 16, 2021

SELL
$6.02 - $9.64 $95,675 - $153,208
-15,893 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$9.17 - $14.8 $24,648 - $39,782
2,688 Added 20.36%
15,893 $150,000
Q4 2020

Feb 16, 2021

SELL
$8.92 - $13.29 $35,082 - $52,269
-3,933 Reduced 22.95%
13,205 $149,000
Q3 2020

Nov 16, 2020

BUY
$9.94 - $16.59 $48,755 - $81,373
4,905 Added 40.1%
17,138 $183,000
Q2 2020

Aug 14, 2020

BUY
$12.07 - $19.34 $147,652 - $236,586
12,233 New
12,233 $186,000

Others Institutions Holding FIXX

About Homology Medicines, Inc.


  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.